Clinical Trial Update: Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung Infections [Phase 1]

View source ↗

Summary

Phase 1 trial update describing safety considerations for combining intravenous antibiotics with bacteriophage therapy in adults with cystic fibrosis and antibi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achromobacter Infection
• Cystic Fibrosis
• Escherichia Coli Infection
• Klebsiella Pneumoniae Infection
• Staphylococcus Aureus Infection
• Stenotrophomonas Maltophilia Infection

Drugs mentioned

• Bacteriophage therapy
• Intravenous antibiotic (unspecified)

Snippet

Sponsor: University of California, San Diego | Conditions: CF - Cystic Fibrosis, Klebsiella Pneumoniae Infection | Phase 1 | Status: NOT_YET_RECRUITING